Lin X Wu

US Patent:

7142538, Nov 28, 2006

Filed:

Dec 22, 2001

Appl. No.:

10/027926

Inventors:

Ashok Kumar Singh - Irvine CA, US
Lin Wu - Sunnyvale CA, US
Dapeng Xiong - Irvine CA, US
Celine Yonghong Wang - Irvine CA, US

Assignee:

ADC DSL Systems, Inc. - Eden Praire MN

International Classification:

H04L 12/28
H04L 12/56

US Classification:

370392, 3703951

Abstract:

A method for communicating between cards in an electronic module is provided. The method includes generating a message for transmission at a first card. The message is transmitted over a bus to a second card by-passing an IP stack at the first card. A queue at the second card is monitored for messages from the first card. A message is read from the queue at the second card when received from the first card.

US Patent:

20080153840, Jun 26, 2008

Filed:

Dec 20, 2007

Appl. No.:

11/961860

Inventors:

Luiz Belardinelli - Palo Alto CA, US
Lin Wu - Sunnyvale CA, US
Sridharan Rajamani - Fremont CA, US
Arvinder Dhalla - Mountain View CA, US

International Classification:

A61K 31/496
A61P 9/00

US Classification:

51425212

Abstract:

The present application discloses methods for treating patients with a dysfunction of the ion channels of the heart suffering from one or more cardiovascular diseases to reduce the proarrhythmic effect of drugs and/or conditions that reduce or inhibit I.

US Patent:

20100173294, Jul 8, 2010

Filed:

Jul 30, 2009

Appl. No.:

12/512914

Inventors:

Rachel Langland - Oakland CA, US
Lin Wu - Moraga CA, US
Thad Sharp - Parsippany NJ, US
Stephen Will - Rotkreuz, CH

Assignee:

ROCHE MOLECULAR SYSTEMS, INC. - Pleasanton CA

International Classification:

C12Q 1/68

US Classification:

435 6

Abstract:

The present invention provides methods and reagents for the detection of a mutation in BRAF and methods of selecting patients for treatment if a B-Raf kinase inhibitor, such as a selective B-Raf kinase inhibitor

US Patent:

20110212991, Sep 1, 2011

Filed:

Jan 27, 2011

Appl. No.:

13/015374

Inventors:

Rachel Langland - Oakland CA, US
Lin Wu - Moraga CA, US
Thad Sharp - Parsippany NJ, US
Stephen Will - Cham, CH

Assignee:

ROCHE MOLECULAR SYSTEMS, INC. - Pleasanton CA

International Classification:

A61K 31/437
C12Q 1/68
C07H 21/04
A61P 35/00

US Classification:

514300, 435 611, 536 2431

Abstract:

The present invention provides methods and reagents for the detection of a mutation in BRAF and methods of selecting, patients for treatment if a B-Raf kinase inhibitor, such as a selective B-Raf kinase inhibitor.

US Patent:

58540032, Dec 29, 1998

Filed:

Feb 26, 1998

Appl. No.:

/032475

Inventors:

Mike Rothe - San Mateo CA
Lin Wu - South San Francisco CA

Assignee:

Tularik Inc. - South San Francisco CA

International Classification:

G01N 33566

US Classification:

435 78

Abstract:

The invention provides methods and compositions relating to a novel kinase, NIK, involved in NF. kappa. B activation. The polypeptides may be produced recombinantly from transformed host cells from the disclosed NIK encoding nucleic acids or purified from human cells. The invention provides isolated NIK hybridization probes and primers capable of specifically hybridizing with the disclosed NIK genes, NIK-specific binding agents such as specific antibodies, and methods of making and using the subject compositions in diagnosis, therapy and in the biopharmaceutical industry.

US Patent:

58440739, Dec 1, 1998

Filed:

Feb 13, 1998

Appl. No.:

/023321

Inventors:

Mike Rothe - San Mateo CA
Lin Wu - South San Francisco CA

Assignee:

Tularik Inc. - South San Francisco CA

International Classification:

C07K 412
C07K 706
C07K 708
C07K 1447

US Classification:

530300

Abstract:

The invention provides methods and compositions relating to a novel kinase, NIK, involved in NF. kappa. B activation. The polypeptides may be produced recombinantly from transformed host cells from the disclosed NIK encoding nucleic acids or purified from human cells. The invention provides isolated NIK hybridization probes and primers capable of specifically hybridizing with the disclosed NIK genes, NIK-specific binding agents such as specific antibodies, and methods of making and using the subject compositions in diagnosis, therapy and in the biopharmaceutical industry.

US Patent:

58437215, Dec 1, 1998

Filed:

Jul 3, 1997

Appl. No.:

8/887518

Inventors:

Mike Rothe - San Mateo CA
Lin Wu - South San Francisco CA

Assignee:

Tularik Inc. - South San Francisco CA

International Classification:

C12P 2106
C12N 100
C12N 510
C12N 1512

US Classification:

435 692

Abstract:

The invention provides methods and compositions relating to a novel kinase, NIK, involved in NF. kappa. B activation. The polypeptides may be produced recombinantly from transformed host cells from the disclosed NIK encoding nucleic acids or purified from human cells. The invention provides isolated NIK hybridization probes and primers capable of specifically hybridizing with the disclosed NIK genes, NIK-specific binding agents such as specific antibodies, and methods of making and using the subject compositions in diagnosis, therapy and in the biopharmaceutical industry.

US Patent:

20170067122, Mar 9, 2017

Filed:

Nov 4, 2016

Appl. No.:

15/344364

Inventors:

- Pleasanton CA, US
Lin Wu - Moraga CA, US
Thad Sharp - Parsippany NJ, US
Stephen Will - Oakland CA, US

International Classification:

C12Q 1/68

Abstract:

The present invention provides methods and reagents for the detection of a mutation in BRAF and methods of selecting patients for treatment if a B-Raf kinase inhibitor, such as a selective B-Raf kinase inhibitor.